Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people worldwide. Published in the Journal of Neuroscience, new research from the ...

Northwestern University researchers have reported that levetiracetam, a long-established anti-epileptic medicine, prevented ...

Behavioral assays linked these molecular disturbances to functional outcomes. Exposed fish displayed increased locomotor activity, heightened anxiety-like behavior, and altered learning performance, ...

While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in ...

Researchers find that a common glaucoma drug, acetazolamide, can reverse brain changes and prevent relapse in opioid use disorder.

A study published in Molecular Psychiatry reveals a path of cause-effect molecular events that can lead to Alzheimer's ...

An existing drug currently used to treat glaucoma, altitude sickness, and seizures may also have the potential to prevent ...

Animation shows what happens inside a neuron during the synaptic vesicle cycle and how administering levetiracetam enables APP to remain on the cell’s surface longer, diverting it away from the ...